Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. announced that it has been recognized by M&A Today’s Global Awards as the 2014 “Law Firm of the Year (Biotechnology) – North America.” M&A Today’s Global Awards program identifies “industry leaders, exemplary teams and distinguished organizations, based on the simple principles of veracity, accuracy and insight.”

Recipients of M&A Today’s Global Awards are evaluated by an independent panel of judges based on the scale, complexity and strategic nature of the work conducted. In order to be considered, firms must receive no fewer than 18% of votes from the global readership, currently in excess of 151,000. The 2014 winners will be recognized in special edition of M&A Today.

“We are honored to be named the top biotechnology law firm in North America,” said William T. Whelan, Co-chair of Mintz Levin’s Life Sciences Practice. “We very much appreciate this recognition of the strength of our team and our commitment to helping our clients meet their goals.”

Mintz Levin has served as one of the leading law firms to the life sciences industry since the industry’s birth in the 1970s. Today, the firm advises hundreds of businesses and other organizations in all sectors of the industry’s ecosystem -- from start-ups looking for their first funding to public companies with products on the market, as well as venture capital firms, investment banks, and research and academic institutions. Mintz Levin attorneys provide experienced counsel to clients globally in a broad range of matters, including corporate finance and securities, mergers and acquisitions, licensing and collaborations, intellectual property, litigation, regulatory, employment and benefits, bankruptcy and commercial lending, immigration, and real estate. Mintz Levin is a full-service law firm comprised of 450 attorneys with eight offices (Boston, New York, San Diego, San Francisco, Washington, Stamford, Los Angeles, and London) and an affiliate relationship in Israel.